person · Reporting owner
KUEBLER CHRISTOPHER A
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NEKTAR THERAPEUTICSNKTR · Entity 4364 | Director | September 27, 2018 | October 02, 2018 |
| WATERS CORP /DE/WAT · Entity 3080 | Director | August 06, 2026 | August 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NEKTAR THERAPEUTICS
Report date September 27, 2018 · Filed October 02, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 45,250 |
Reported balance
After 2018-09-27 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-09-27 · Grant · Acquired 4,750 · Balance 45,250 F1: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock. F2: This restricted stock unit award vests in full, one year following September 27, 2018. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $60.91 · Expires 2026-09-26 | Direct | 9,500 |
Reported balance
After 2018-09-27 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-09-27 · Grant · Acquired 9,500 · Balance 9,500 F3: This stock option vests in equal monthly installments over the one-year period beginning on September 30, 2018. |
Filing footnotes · ownership attribution and instrument terms
F1: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock.
F2: This restricted stock unit award vests in full, one year following September 27, 2018.
F3: This stock option vests in equal monthly installments over the one-year period beginning on September 30, 2018.
WATERS CORP /DE/
Report date August 06, 2026 · Filed August 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,808 |
Ending reported balance
After 2026-08-06 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-08-06 · Exercise / conversion · Acquired 3,626 · Balance 21,434 Row 2 · 2026-08-06 · Sale · Disposed 3,626 · Balance 17,808 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $136.43 · Expires 2027-01-03 | Direct | 0 |
Reported balance
After 2026-08-06 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-08-06 · Exercise / conversion · Disposed 3,626 · Balance 0 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 09, 2018 Filed Mar 12, 2018 14:59 UTC | WATERS CORP /DE/ WAT · Entity 3080 | Exercise / conversionCommon Stock | 3,584 | $61.63 | $220,881.92 |
DisclosureSEC source: 0001127602-18-011060 · form4.xml · nonDerivative · entry 3 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,495 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2018 Filed Mar 12, 2018 14:59 UTC | WATERS CORP /DE/ WAT · Entity 3080 | SaleCommon Stock | 3,500 | $209.10 | $731,850.00 |
DisclosureSEC source: 0001127602-18-011060 · form4.xml · nonDerivative · entry 2 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,911 Read SEC document |
| March 09, 2018 Filed Mar 12, 2018 14:59 UTC | WATERS CORP /DE/ WAT · Entity 3080 | Exercise / conversionCommon Stock | 3,500 | $38.09 | $133,315.00 |
DisclosureSEC source: 0001127602-18-011060 · form4.xml · nonDerivative · entry 1 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,411 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2018 Filed Mar 9, 2018 17:45 UTC | WATERS CORP /DE/ WAT · Entity 3080 | Exercise / conversionStock Option (Right to Buy) · Derivative | 416 | $0.00 Strike: $61.63 | $0.00 |
DisclosureSEC source: 0001127602-18-010877 · form4.xml · derivative · entry 3 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,584 Underlying: Common Stock · 416 shares Expires 2020-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2018 Filed Mar 9, 2018 17:45 UTC | WATERS CORP /DE/ WAT · Entity 3080 | SaleCommon Stock | 416 | $209.00 | $86,944.00 |
DisclosureSEC source: 0001127602-18-010877 · form4.xml · nonDerivative · entry 2 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,911 Read SEC document |
| March 08, 2018 Filed Mar 9, 2018 17:45 UTC | WATERS CORP /DE/ WAT · Entity 3080 | Exercise / conversionCommon Stock | 416 | $61.63 | $25,638.08 |
DisclosureSEC source: 0001127602-18-010877 · form4.xml · nonDerivative · entry 1 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,327 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2018 Filed Mar 8, 2018 23:10 UTC | NEKTAR THERAPEUTICS NKTR · Entity 4364 | Exercise / conversionStock Option · Derivative | 10,000 | $0.00 Strike: $9.24 | $0.00 |
DisclosureSEC source: 0001209191-18-018223 · doc4.xml · derivative · entry 8 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 10,000 shares Expires 2020-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2018 Filed Mar 8, 2018 23:10 UTC | NEKTAR THERAPEUTICS NKTR · Entity 4364 | Exercise / conversionStock Option · Derivative | 27,400 | $0.00 Strike: $5.14 | $0.00 |
DisclosureSEC source: 0001209191-18-018223 · doc4.xml · derivative · entry 7 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,400 shares Expires 2019-09-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2018 Filed Mar 8, 2018 23:10 UTC | NEKTAR THERAPEUTICS NKTR · Entity 4364 | SaleCommon Stock | 37,400 | $97.41 | $3,643,134.00 |
DisclosureSEC source: 0001209191-18-018223 · doc4.xml · nonDerivative · entry 5 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,500 F2 · price: This transaction was executed in multiple trades at prices ranging from $96.02 to $98.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| March 07, 2018 Filed Mar 8, 2018 23:10 UTC | NEKTAR THERAPEUTICS NKTR · Entity 4364 | Exercise / conversionCommon Stock | 10,000 | $9.24 | $92,400.00 |
DisclosureSEC source: 0001209191-18-018223 · doc4.xml · nonDerivative · entry 4 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2018 Filed Mar 8, 2018 23:10 UTC | NEKTAR THERAPEUTICS NKTR · Entity 4364 | Exercise / conversionCommon Stock | 27,400 | $5.14 | $140,836.00 |
DisclosureSEC source: 0001209191-18-018223 · doc4.xml · nonDerivative · entry 3 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 23:10 UTC | NEKTAR THERAPEUTICS NKTR · Entity 4364 | Exercise / conversionStock Option · Derivative | 2,600 | $0.00 Strike: $5.14 | $0.00 |
DisclosureSEC source: 0001209191-18-018223 · doc4.xml · derivative · entry 6 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,400 Underlying: Common Stock · 2,600 shares Expires 2019-09-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 23:10 UTC | NEKTAR THERAPEUTICS NKTR · Entity 4364 | SaleCommon Stock | 2,600 | $100.30 | $260,780.00 |
DisclosureSEC source: 0001209191-18-018223 · doc4.xml · nonDerivative · entry 2 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,500 F1 · price: This transaction was executed in multiple trades at prices ranging from $100.00 to $101.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 23:10 UTC | NEKTAR THERAPEUTICS NKTR · Entity 4364 | Exercise / conversionCommon Stock | 2,600 | $5.14 | $13,364.00 |
DisclosureSEC source: 0001209191-18-018223 · doc4.xml · nonDerivative · entry 1 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 21:17 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantStock Option (Right to Buy) · Derivative | 2,692 | $0.00 Strike: $195.69 | $0.00 |
DisclosureSEC source: 0001127602-18-000606 · form4.xml · derivative · entry 3 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,692 Underlying: Common Stock · 2,692 shares Expires 2028-01-02 F4 · derivative.exercise_date: Options fully vest on January 2, 2019. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 21:17 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantCommon Stock | 562 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-000606 · form4.xml · nonDerivative · entry 1 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,911 F1 · shares: Grant of shares of common stock subject to restrictions that lapse January 2, 2019. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 23:01 UTC | NEKTAR THERAPEUTICS NKTR · Entity 4364 | Exercise / conversionStock Option · Derivative | 30,000 | $0.00 Strike: $14.26 | $0.00 |
DisclosureSEC source: 0001209191-18-002177 · doc4.xml · derivative · entry 3 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2018-09-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for stock options expiring in 2018. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 23:01 UTC | NEKTAR THERAPEUTICS NKTR · Entity 4364 | SaleCommon Stock | 30,000 | $58.66 | $1,759,800.00 |
DisclosureSEC source: 0001209191-18-002177 · doc4.xml · nonDerivative · entry 2 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,500 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for stock options expiring in 2018. F2 · price: This transaction was executed in multiple trades at prices ranging from $57.81 to $59.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 23:01 UTC | NEKTAR THERAPEUTICS NKTR · Entity 4364 | Exercise / conversionCommon Stock | 30,000 | $14.26 | $427,800.00 |
DisclosureSEC source: 0001209191-18-002177 · doc4.xml · nonDerivative · entry 1 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for stock options expiring in 2018. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 21:17 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantPhantom Stock Units · Derivative | 115.23 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-000606 · form4.xml · derivative · entry 2 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115.23 Underlying: Common Stock · 115.23 shares Expires not disclosed F2 · derivative.exercise_price: COMMON STOCK UNITS ARE CONVERTIBLE INTO COMMON STOCK SHARES ON A ONE TO ONE RATIO. F3 · derivative.expiration_date: UPON RESIGNATION AS DIRECTOR. Read SEC document |
| September 30, 2017 Filed Oct 3, 2017 18:47 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantPhantom Stock Units · Derivative | 106.17 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-028866 · form4.xml · derivative · entry 2 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106.17 Underlying: Common Stock · 106.17 shares Expires not disclosed F1 · derivative.exercise_price: COMMON STOCK UNITS ARE CONVERTIBLE INTO COMMON STOCK SHARES ON A ONE TO ONE RATIO. F2 · derivative.expiration_date: UPON RESIGNATION AS DIRECTOR. Read SEC document |
| September 22, 2017 Filed Sep 25, 2017 22:03 UTC | NEKTAR THERAPEUTICS NKTR · Entity 4364 | SaleCommon Stock | 4,000 | $21.86 | $87,440.00 |
DisclosureSEC source: 0001209191-17-053879 · doc4.xml · nonDerivative · entry 1 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,500 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| September 19, 2017 Filed Sep 21, 2017 20:56 UTC | NEKTAR THERAPEUTICS NKTR · Entity 4364 | GrantStock Option · Derivative | 22,500 | $0.00 Strike: $21.75 | $0.00 |
DisclosureSEC source: 0001209191-17-053623 · doc4.xml · derivative · entry 2 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: common stock · 22,500 shares Expires 2025-09-18 F3 · derivative.exercise_date: This stock option vests in equal monthly installments over the one-year period beginning on September 30, 2017. Read SEC document |
| September 19, 2017 Filed Sep 21, 2017 20:56 UTC | NEKTAR THERAPEUTICS NKTR · Entity 4364 | GrantCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-053623 · doc4.xml · nonDerivative · entry 1 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,500 F1 · security: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock. F2 · deemedExecutionDate: This restricted stock unit award vests in full, one year following September 19, 2017. Read SEC document |
| August 08, 2017 Filed Aug 9, 2017 10:27 UTC | WATERS CORP /DE/ WAT · Entity 3080 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,500 | $0.00 Strike: $76.75 | $0.00 |
DisclosureSEC source: 0001127602-17-025272 · form4.xml · derivative · entry 3 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,500 shares Expires 2018-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 08, 2017 Filed Aug 9, 2017 10:27 UTC | WATERS CORP /DE/ WAT · Entity 3080 | SaleCommon Stock | 3,500 | $179.67 | $628,845.00 |
DisclosureSEC source: 0001127602-17-025272 · form4.xml · nonDerivative · entry 2 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,349 Read SEC document |
| August 08, 2017 Filed Aug 9, 2017 10:27 UTC | WATERS CORP /DE/ WAT · Entity 3080 | Exercise / conversionCommon Stock | 3,500 | $76.75 | $268,625.00 |
DisclosureSEC source: 0001127602-17-025272 · form4.xml · nonDerivative · entry 1 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,849 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 19:48 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantPhantom Stock Units · Derivative | 122.3 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-022904 · form4.xml · derivative · entry 2 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122.3 Underlying: Common Stock · 122.3 shares Expires not disclosed F1 · derivative.exercise_price: COMMON STOCK UNITS ARE CONVERTIBLE INTO COMMON STOCK SHARES ON A ONE TO ONE RATIO. F2 · derivative.expiration_date: UPON RESIGNATION AS DIRECTOR. Read SEC document |
| April 05, 2017 Filed Apr 7, 2017 22:01 UTC | NEKTAR THERAPEUTICS NKTR · Entity 4364 | Exercise / conversionStock Option · Derivative | 15,000 | $0.00 Strike: $8.37 | $0.00 |
DisclosureSEC source: 0001209191-17-026342 · doc4.xml · derivative · entry 3 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2017-09-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 05, 2017 Filed Apr 7, 2017 22:01 UTC | NEKTAR THERAPEUTICS NKTR · Entity 4364 | SaleCommon Stock | 15,000 | $21.88 | $328,200.00 |
DisclosureSEC source: 0001209191-17-026342 · doc4.xml · nonDerivative · entry 2 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,500 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: This transaction was executed in multiple trades at prices ranging from $21.58 to $22.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| April 05, 2017 Filed Apr 7, 2017 22:01 UTC | NEKTAR THERAPEUTICS NKTR · Entity 4364 | Exercise / conversionCommon Stock | 15,000 | $8.37 | $125,550.00 |
DisclosureSEC source: 0001209191-17-026342 · doc4.xml · nonDerivative · entry 1 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 17:22 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantPhantom Stock Units · Derivative | 102.11 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-013751 · form4.xml · derivative · entry 2 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102.11 Underlying: Common Stock · 102.11 shares Expires not disclosed F1 · derivative.exercise_price: COMMON STOCK UNITS ARE CONVERTIBLE INTO COMMON STOCK SHARES ON A ONE TO ONE RATIO. F2 · derivative.expiration_date: UPON RESIGNATION AS DIRECTOR. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 20:48 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantStock Option (Right to Buy) · Derivative | 3,626 | $0.00 Strike: $136.43 | $0.00 |
DisclosureSEC source: 0001127602-17-001027 · form4.xml · derivative · entry 2 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,626 Underlying: Common Stock · 3,626 shares Expires 2027-01-03 F2 · derivative.exercise_date: Options fully vest on January 3, 2018. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 20:48 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantCommon Stock | 806 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-001027 · form4.xml · nonDerivative · entry 1 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,349 F1 · shares: Grant of shares of common stock subject to restrictions that lapse January 3, 2018. Read SEC document |
| December 31, 2016 Filed Jan 3, 2017 21:23 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantPhantom Stock Units · Derivative | 148.89 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-000208 · form4.xml · derivative · entry 2 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148.89 Underlying: Common Stock · 148.89 shares Expires not disclosed F1 · derivative.exercise_price: COMMON STOCK UNITS ARE CONVERTIBLE INTO COMMON STOCK SHARES ON A ONE TO ONE RATIO. F2 · derivative.expiration_date: UPON RESIGNATION AS DIRECTOR. Read SEC document |
| September 30, 2016 Filed Oct 3, 2016 14:21 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantPhantom Stock Units · Derivative | 98.55 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-063599 · form4.xml · derivative · entry 2 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98.55 Underlying: Common Stock · 98.55 shares Expires not disclosed F1 · derivative.exercise_price: COMMON STOCK UNITS ARE CONVERTIBLE INTO COMMON STOCK SHARES ON A ONE TO ONE RATIO. F2 · derivative.expiration_date: UPON RESIGNATION AS DIRECTOR. Read SEC document |
| September 21, 2016 Filed Sep 23, 2016 21:11 UTC | NEKTAR THERAPEUTICS NKTR · Entity 4364 | GrantStock Option · Derivative | 20,000 | $0.00 Strike: $19.15 | $0.00 |
DisclosureSEC source: 0001209191-16-142667 · doc4.xml · derivative · entry 2 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2024-09-20 F3 · derivative.exercise_date: This option vests in equal monthly installments over the one-year period beginning on September 30, 2016. Read SEC document |
| September 21, 2016 Filed Sep 23, 2016 21:11 UTC | NEKTAR THERAPEUTICS NKTR · Entity 4364 | GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-142667 · doc4.xml · nonDerivative · entry 1 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,500 F1 · security: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock. F2 · deemedExecutionDate: This restricted stock unit award vests in full, one year following September 21, 2016. Read SEC document |
| September 16, 2016 Filed Sep 19, 2016 21:15 UTC | NEKTAR THERAPEUTICS NKTR · Entity 4364 | SaleCommon Stock | 7,500 | $19.13 | $143,475.00 |
DisclosureSEC source: 0001209191-16-142026 · doc4.xml · nonDerivative · entry 2 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,500 F3 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: This transaction was executed in multiple trades at prices ranging from $18.94 to $19.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| September 15, 2016 Filed Sep 19, 2016 21:15 UTC | NEKTAR THERAPEUTICS NKTR · Entity 4364 | Exercise / conversionRestricted Stock Unit · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-142026 · doc4.xml · derivative · entry 3 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents restricted stock units ("RSU"), convertible on a one-for-one basis into shares of Common Stock of the Company. These RSUs, at the time of their grant on September 15, 2015, vested in full one year following the grant date. F1 · derivative.exercise_date: Represents restricted stock units ("RSU"), convertible on a one-for-one basis into shares of Common Stock of the Company. These RSUs, at the time of their grant on September 15, 2015, vested in full one year following the grant date. F1 · derivative.expiration_date: Represents restricted stock units ("RSU"), convertible on a one-for-one basis into shares of Common Stock of the Company. These RSUs, at the time of their grant on September 15, 2015, vested in full one year following the grant date. Read SEC document |
| September 15, 2016 Filed Sep 19, 2016 21:15 UTC | NEKTAR THERAPEUTICS NKTR · Entity 4364 | Exercise / conversionCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-142026 · doc4.xml · nonDerivative · entry 1 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents restricted stock units ("RSU"), convertible on a one-for-one basis into shares of Common Stock of the Company. These RSUs, at the time of their grant on September 15, 2015, vested in full one year following the grant date. F2 · balance_after: The total holdings include 15,000 shares of restricted stock units ("RSUs") that were previously reported in Table II for the reporting person and which are being reclassified to Table I. These RSUs were granted on September 15, 2015, are convertible on a one-for-one basis into shares of Common Stock of the Company and vested on September 15, 2016. Read SEC document |
| January 04, 2016 Filed Jan 5, 2017 20:21 UTC Amendment | WATERS CORP /DE/ WAT · Entity 3080 | GrantStock Option (Right to Buy) · Derivative | 3,761 | $0.00 Strike: $130.35 | $0.00 |
DisclosureSEC source: 0001127602-17-001015 · form4a.xml · derivative · entry 2 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,761 Underlying: Common Stock · 3,761 shares Expires 2026-01-04 F1 · shares: The purpose of this amended filing is to correctly report the number of stock and stock option awards. F3 · derivative.exercise_date: Options fully vest on January 4, 2017. Read SEC document |
| January 04, 2016 Filed Jan 5, 2017 20:21 UTC Amendment | WATERS CORP /DE/ WAT · Entity 3080 | GrantCommon Stock | 843 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-001015 · form4a.xml · nonDerivative · entry 1 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,543 F1 · shares: The purpose of this amended filing is to correctly report the number of stock and stock option awards. F2 · shares: Grant of shares of common stock subject to restrictions that lapse January 4, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.